Zebra Capital Management LLC Precigen, Inc. Transaction History

Zebra Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.91 - $3.98 $23,810 - $49,614	-12,466 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$3.53 - $5.5 $16,223 - $25,278	-4,596 Reduced 26.94%	12,466 $46,000
Q3 2021 Nov 15, 2021	SELL	$4.99 - $6.55 $1,926 - $2,528	-386 Reduced 2.21%	17,062 $85,000
Q2 2021 Aug 16, 2021	SELL	$6.24 - $8.22 $11,756 - $15,486	-1,884 Reduced 9.75%	17,448 $114,000
Q1 2021 May 17, 2021	BUY	$6.74 - $10.95 $130,297 - $211,685	19,332 New	19,332 $133,000

143

144M

292K

53.8K

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $198M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

Get notified when there are updates to the investment portfolio of Zebra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Zebra Capital Management LLC with notifications on news.